GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 37 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $683,544 | -30.3% | 297,193 | -2.4% | 0.05% | -39.2% |
| Q3 2022 | $981,000 | -41.0% | 304,582 | +0.8% | 0.08% | -40.6% |
| Q2 2022 | $1,662,000 | +212.4% | 302,182 | +32.4% | 0.13% | +411.5% |
| Q1 2022 | $532,000 | -59.9% | 228,149 | +3.9% | 0.03% | -58.7% |
| Q4 2021 | $1,327,000 | -40.0% | 219,641 | +37.7% | 0.06% | -67.9% |
| Q3 2021 | $2,212,000 | +18.1% | 159,491 | +10.7% | 0.20% | +21.0% |
| Q2 2021 | $1,873,000 | -8.7% | 144,055 | +8.1% | 0.16% | -17.3% |
| Q1 2021 | $2,052,000 | – | 133,276 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|